Home
Conditions
Urologic Diseases

Clinical trial condition

Urologic Diseases

Explore clinical trials studying Urologic Diseases. Study availability and eligibility vary by location and protocol.

13,592 public trials 2,146 recruiting studies

Refine in advanced search Browse all conditions

Urologic Diseases trial results

Active, Not Recruiting

Neoadjuvant Study With Combination Immuno-oncology for Primary Clear Cell Renal Cell Cancer

NCT05148546

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Netherlands Cancer Institute Amsterdam, North Holland, Netherlands

Royal Free London NHS Foundation Trust London, United Kingdom

View Trial Details

Active, Not Recruiting

Meta-Analyses of the Effect of Plant Protein Versus Animal Protein on Cardiometabolic Risk

NCT02037321

Conditions: Arthritis, Body Weight, Cardiovascular Disease, +48 more
Locations: Toronto 3-D (Diet, Digestive tract and Disease) Knowledge Synthesis and Clinical Trials Unit, Clinical Nutrition and Risk Factor Modification Centre, St. Michael's Hospital Toronto, Ontario, Canada

View Trial Details

Active, Not Recruiting

Atacicept in Subjects With IgA Nephropathy

NCT04716231

Conditions: Autoimmune Diseases, Berger Disease, Female Urogenital Diseases, +10 more
Locations: ORIGIN 3 Global Site Contact Information Brisbane, California, United States

View Trial Details

Active, Not Recruiting

Prevelance of Hypercalciuria in Children With Steroid Dependent Nephrotic Syndrome

NCT07194213

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hupercalciurea, +12 more
Locations: Sohag university hospital Sohag, Egypt

Sohag university hospital Sohag, Egypt

View Trial Details

Active, Not Recruiting

A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Urological Tumors and Other Solid Tumors

NCT05393427

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

Peking University First Hospital Beijing, Beijing Municipality, China

Chongqing University Cancer Hospital Chongqing, Chongqing Municipality, China

West China Hospital, Sichuan University Chengdu, Sichuan, China

View Trial Details

Active, Not Recruiting

A Study of SI-B003, a PD-1/CTLA-4 Bispecific Antibody, in Patients With Advanced Solid Tumors

NCT04606472

Conditions: Adenocarcinoma, Breast Diseases, Breast Neoplasms, +43 more
Locations: Beijing Cancer Hospital Beijing, Beijing Municipality, China

Chongqing University Cancer Hospital Chongqing, Chongqing Municipality, China

The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China

Henan Cancer Hospital Zhengzhou, Henan, China

View Trial Details

Active, Not Recruiting

Darbepoetin Alfa Once Monthly Dosing Schedule Maintains Hemoglobin Concentration Comparable to Every 2 Weeks Dosing Schedule in Advanced Chronic Kidney Disease Patients Not on Dialysis: A Multicenter, Phase 4 Study

NCT07025460

Conditions: Chronic Disease, Chronic Kidney Disease, Disease Attributes, +10 more
Locations: Institutional Review Board, Gangnam Severance Hospitial Yonsei University College of Medicine Seoul, South Korea

View Trial Details

Active, Not Recruiting

A Study of Nivolumab In Combination With Cabozantinib in Patients With Non-Clear Cell Renal Cell Carcinoma

NCT03635892

Conditions: Adenocarcinoma, Advanced or Metastatic Non-clear Cell Renal Cell Carcinoma, Carcinoma, +20 more
Locations: Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States

Memorial Sloan Kettering Bergen Montvale, New Jersey, United States

Memorial Sloan Kettering Commack Commack, New York, United States

View Trial Details

Active, Not Recruiting

AB-2100, an Integrated Circuit T Cell Therapy in Patients With Recurrent Clear-cell Renal Cell Carcinoma (ccRCC)

NCT06245915

Conditions: Adenocarcinoma, Advanced/Metastatic Clear Cell Renal Cell Carcinoma, Carcinoma, +19 more
Locations: Mayo Clinic Hospital Phoenix, Arizona, United States

City of Hope Duarte, California, United States

Moffitt Cancer Center Tampa, Florida, United States

University of Iowa and Holden Comprehensive Cancer Center Iowa City, Iowa, United States

View Trial Details

Active, Not Recruiting

Serological Autoantibodies in Early Kidney Cancer Diagnosis and Prognosis: A Multicenter Study

NCT06917560

Conditions: Adenocarcinoma, Autoantibody, Carcinoma, +16 more
Locations: first hospital affiliated of Fujian medical university Fuzhou, Fujian, China

View Trial Details

Urologic Diseases

Urologic Diseases trial results

Related conditions